AB — AB Science SA Income Statement
0.000.00%
Last trade - 00:00- €97.55m
- €102.13m
- €0.96m
Annual income statement for AB Science SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.7 | 1.57 | 1.58 | 1.61 | 0.958 |
| Cost of Revenue | |||||
| Gross Profit | 1.45 | 1.39 | 1.51 | 1.5 | 0.927 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 30.6 | 19 | 16.3 | 15.4 | 16.9 |
| Operating Profit | -28.9 | -17.5 | -14.7 | -13.8 | -15.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26.1 | -21.7 | -15 | -14.4 | -13.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -26.1 | -21.7 | -15 | -14.5 | -13.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -26.1 | -21.7 | -15 | -14.5 | -13.6 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26.1 | -21.7 | -15 | -14.5 | -13.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.69 | -0.552 | -0.34 | -0.304 | -0.289 |
| Dividends per Share |